| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.039 | 0.8 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |